A Registry Study on HIV-related Lymphoma

Launched by ROTKREUZKLINIKUM MÜNCHEN GGMBH · Jan 28, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at patients with HIV who have been diagnosed with lymphoma, a type of cancer that affects the lymphatic system. The study aims to gather information about the characteristics of these patients, the types of treatments they receive, any side effects they experience, and how well those treatments work. Researchers will collect data from both past and ongoing cases to better understand how to help patients with HIV-related lymphoma.

To participate in this study, individuals must be at least 18 years old and have a confirmed diagnosis of either non-Hodgkin lymphoma or Hodgkin lymphoma while also being diagnosed with HIV at the same time. Participants will need to provide written consent to join the study. If someone was diagnosed with HIV more than three months after their lymphoma diagnosis, they will not be eligible. Those who take part can expect to contribute to important research that could improve treatment strategies for future patients facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Histology or cytology proven non-Hodgkin lymphoma or Hodgkin lymphoma
• • HIV-infection at time of lymphoma diagnosis
• • Lymphoma diagnosis since 01.01.2010
• • Adult patients ≥ 18 years
• • Written informed consent
• Exclusion Criteria:
• • HIV-diagnosis \> 3 months after the diagnosis of malignant lymphoma
• • Non-Compliance or lack of opportunity for follow-up (for the prospective part of the study)